Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare Conference
September 06 2023 - 3:15PM
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an
innovative life sciences technology company providing mission
critical automation solutions to facilitate the efficient
manufacturing and fast, safe release of healthcare products, today
announced that the Company will participate in the Morgan Stanley
21st Annual Global Healthcare Conference.
Rob Spignesi, President and CEO, and Sean
Wirtjes, CFO, are scheduled to participate in a 30-minute
question-and-answer session with the host analyst on Tuesday,
September 12, 2023 at 7:30 a.m. Eastern Time. A live webcast of the
presentation will be available on the Rapid Micro Biosystems
investor relations website at https://investors.rapidmicrobio.com/
and can be accessed here. The webcast will be archived and
available for replay for at least 180 days after the event.
About Rapid Micro
Biosystems
Rapid Micro Biosystems is an innovative life
sciences technology company providing mission critical automation
solutions to facilitate the efficient manufacturing and fast, safe
release of healthcare products such as biologics, vaccines, cell
and gene therapies, and sterile injectables. The Company’s flagship
Growth Direct System automates and modernizes the antiquated,
manual microbial quality control (“MQC”) testing workflows used in
the largest and most complex pharmaceutical manufacturing
operations across the globe. The Growth Direct System brings the
quality control lab to the manufacturing floor, unlocking the power
of MQC automation to deliver the faster results, greater accuracy,
increased operational efficiency, better compliance with data
integrity regulations, and quicker decision making that customers
rely on to ensure safe and consistent supply of important
healthcare products. The Company is headquartered and has U.S.
manufacturing in Lowell, Massachusetts, with global locations in
Lexington, Massachusetts, Switzerland, Germany, and the
Netherlands. For more information, please
visit www.rapidmicrobio.com or follow the Company on
Twitter at @rapidmicrobio or on LinkedIn.
Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
mbeaulieu@rapidmicrobio.com
Media Contact:
media@rapidmicrobio.com
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From May 2024 to Jun 2024
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From Jun 2023 to Jun 2024